Hanna Roenfanz, PhD

Associate Director, Analytical Sciences
Hartford Hospital
Hartford, Connecticut, United States

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 207 - Ex vivo Assessment of Cefepime (FEP) Clearance during Continuous Renal Replacement Therapy (CRRT) and Clinical Validation of Optimized Dosing Regimens

  Thursday, October 17, 2024
  3:15 PM – 3:30 PM US PT